Profile | GDS4284 / 200669_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 8886.36 | 97 |
GSM687648 | Patient 402 control | 7857.57 | 96 |
GSM687653 | Patient 403 control | 7989.73 | 96 |
GSM687658 | Patient 404 control | 8272.79 | 96 |
GSM687663 | Patient 411 control | 7902.71 | 96 |
GSM687668 | Patient 422 control | 9099.67 | 97 |
GSM687673 | Patient 424 control | 10197.1 | 97 |
GSM687678 | Patient 425 control | 9153.82 | 97 |
GSM687683 | Patient 427 control | 8046.93 | 96 |
GSM687688 | Patient 428 control | 6925.82 | 95 |
GSM687695 | Patient 441 control | 28276.6 | 99 |
GSM687699 | Patient 443 control | 10688.5 | 97 |
GSM687704 | Patient 444 control | 6459.53 | 95 |
GSM687707 | Patient 448 control | 8732.48 | 97 |
GSM687712 | Patient 449 control | 8760.26 | 97 |
GSM687719 | Patient 450 control | 11996 | 98 |
GSM687724 | Patient 451 control | 8580.42 | 96 |
GSM687728 | Patient 452 control | 11048.2 | 97 |
GSM687646 | Patient 401 treated 24h | 7302.33 | 96 |
GSM687649 | Patient 402 treated 24h | 8183.46 | 96 |
GSM687665 | Patient 411 treated 24h | 8742.72 | 97 |
GSM687651 | Patient 402 treated 4 weeks | 7406.43 | 96 |
GSM687667 | Patient 411 treated 4 weeks | 7508.52 | 96 |
GSM687670 | Patient 422 treated 24h | 9257.15 | 97 |
GSM687671 | Patient 422 treated 4 weeks | 9636.04 | 97 |
GSM687654 | Patient 403 treated 24h | 7630.59 | 96 |
GSM687675 | Patient 424 treated 24h | 12095.5 | 98 |
GSM687685 | Patient 427 treated 24h | 7428.93 | 96 |
GSM687656 | Patient 403 treated 4 weeks | 8211.49 | 96 |
GSM687677 | Patient 424 treated 4 weeks | 5563.92 | 94 |
GSM687687 | Patient 427 treated 4 weeks | 7092.16 | 96 |
GSM687692 | Patient 428 treated 4h | 6747.62 | 95 |
GSM687716 | Patient 449 treated 4h | 6973.91 | 95 |
GSM687722 | Patient 450 treated 4h | 11285.8 | 98 |
GSM687680 | Patient 425 treated 24h | 8649.83 | 97 |
GSM687690 | Patient 428 treated 24h | 7496.98 | 96 |
GSM687700 | Patient 443 treated 24h | 13703.9 | 98 |
GSM687705 | Patient 444 treated 24h | 7346.9 | 96 |
GSM687714 | Patient 449 treated 24h | 9508.9 | 97 |
GSM687721 | Patient 450 treated 24h | 20025.9 | 99 |
GSM687682 | Patient 425 treated 4 weeks | 5766.2 | 94 |
GSM687694 | Patient 428 treated 4 weeks | 7933.93 | 96 |
GSM687702 | Patient 443 treated 4 weeks | 10058.4 | 97 |
GSM687718 | Patient 449 treated 4 weeks | 6885.12 | 95 |
GSM687723 | Patient 450 treated 4 weeks | 10353.5 | 97 |
GSM687661 | Patient 404 treated 4h | 9806.44 | 97 |
GSM687710 | Patient 448 treated 4h | 10363 | 97 |
GSM687726 | Patient 451 treated 4h | 8935.25 | 97 |
GSM687730 | Patient 452 treated 4h | 2973.51 | 90 |
GSM687660 | Patient 404 treated 24h | 18778.3 | 98 |
GSM687697 | Patient 441 treated 24h | 16707.1 | 98 |
GSM687709 | Patient 448 treated 24h | 10574.9 | 97 |
GSM687725 | Patient 451 treated 24h | 10179.5 | 97 |
GSM687729 | Patient 452 treated 24h | 21036.5 | 98 |
GSM687727 | Patient 451 treated 4 weeks | 5724.53 | 94 |
GSM687731 | Patient 452 treated 4 weeks | 11666.5 | 98 |